☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
3SBio Signs a License Agreement with Samsung Bioepis for its Biosimilars
January 8, 2019
Eli Lilly to Acquire Loxo Oncology for $8B
January 8, 2019
Novartis's SEG101(crizanlizumab) Receives FDA's Breakthrough Therapy(BT) Designation for Sickle Cell Disease
January 8, 2019
PharmaShots Year in Review: Biosimilars Approvals in 2018
January 8, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions